{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-005020","form_type":"8-K","ticker":"DTSQ","cik":"0002017950","company_name":"DT Cloud Star Acquisition Corp","filed_at":"2026-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.000491+00:00","generated_at":"2026-05-16T05:05:32.766802+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"DT Cloud Star to merge with PrimeGen US in $1.5B SPAC deal; target advances stem cell therapy","bullets":["Deal implies ~$1.5B equity value for PrimeGen US; expected to close in H2 2026 subject to approvals.","PrimeGen's Triple Activated MSC platform targets acute liver failure; completed FDA Pre-IND meeting Dec 17, 2025.","Combined company to list on Nasdaq under a new ticker; proceeds to fund clinical development and commercialization.","Transaction requires stockholder approvals, HSR clearance, and minimum cash conditions; closing not guaranteed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-005020","json":"https://secwatch.observer/filing/0001493152-26-005020.json","markdown":"https://secwatch.observer/filing/0001493152-26-005020.md","text":"https://secwatch.observer/filing/0001493152-26-005020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2017950/000149315226005020/0001493152-26-005020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2017950/000149315226005020/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T05:05:32.766802+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}